Biologic and Medical Imaging Reagents Market

Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
Biologic and Medical Imaging Reagents Market contains market size and forecasts of Biologic and Medical Imaging Reagents in Global, including the following market information:

• Global Biologic and Medical Imaging Reagents Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Biologic and Medical Imaging Reagents market was valued at 21810 million in 2021 and is projected to reach US$ 39380 million by 2028, at a CAGR of 8.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nuclear Imaging (PET & SPECT) Reagents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biologic and Medical Imaging Reagents include Cardinal Health, Bracco, Bayer HealthCare, Curium Pharma, Hengrui Medicine, GE Healthcare, Lantheus Medical Imaging, Novartis (AAA) and Thermo Fisher Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biologic and Medical Imaging Reagents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologic and Medical Imaging Reagents Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biologic and Medical Imaging Reagents Market Segment Percentages, by Type, 2021 (%)

• Nuclear Imaging (PET & SPECT) Reagents
• Magnetic Resonance Imaging (MRI) Reagents
• Fluorescence Imaging Reagents
• Ultrasound and X-ray Contrast Reagents
• Other

Global Biologic and Medical Imaging Reagents Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biologic and Medical Imaging Reagents Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other

Global Biologic and Medical Imaging Reagents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biologic and Medical Imaging Reagents Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Biologic and Medical Imaging Reagents revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Biologic and Medical Imaging Reagents revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Cardinal Health
• Bracco
• Bayer HealthCare
• Curium Pharma
• Hengrui Medicine
• GE Healthcare
• Lantheus Medical Imaging
• Novartis (AAA)
• Thermo Fisher Scientific
• Jubilant DraxImage
• PerkinElmer
• Guerbet
• Nihon Medi-Physics
• YRPG

To know more about market statistics, Download a FREE Sample copy